(19)
(11) EP 2 968 881 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.10.2019 Bulletin 2019/41

(45) Mention of the grant of the patent:
01.05.2019 Bulletin 2019/18

(21) Application number: 14774821.4

(22) Date of filing: 12.03.2014
(51) International Patent Classification (IPC): 
A61M 31/00(2006.01)
A61M 25/00(2006.01)
A61N 1/36(2006.01)
 A61B 5/00(2006.01)
A61M 37/00(2006.01)
A61B 90/00(2016.01)
(86) International application number:
PCT/US2014/025018
(87) International publication number:
WO 2014/159757 (02.10.2014 Gazette 2014/40)

(54)

APPARATUS FOR DELIVERY OF MEDICATION TO THE BRAIN TO TREAT NEUROLOGICAL CONDITIONS

VORRICHTUNGEN ZUR VERABREICHUNG VON ARZNEIMITTELN IN DAS GEHIRN ZUR BEHANDLUNG VON NEUROLOGISCHEN LEIDEN

APPAREIL D'ADMINISTRATION DE MÉDICAMENT AU CERVEAU POUR TRAITER DES ÉTATS NEUROLOGIQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 14.03.2013 US 201313827468

(43) Date of publication of application:
20.01.2016 Bulletin 2016/03

(73) Proprietor: Incube Labs, LLC
San Jose, CA 95131 (US)

(72) Inventors:
  • IMRAN, Mir
    Los Altos Hills, CA 94022 (US)
  • MORGAN, Phillip
    San Antonio, TX 78205 (US)
  • TRANCHINA, Ben
    Boerne, TX 78015 (US)
  • SPEHR, Paul
    San Antonio, TX 78255 (US)
  • HORLEN, Kyle
    San Antonio, TX 78259 (US)

(74) Representative: Rees, Kerry 
WP Thompson 138 Fetter Lane
London EC4A 1BT
London EC4A 1BT (GB)


(56) References cited: : 
WO-A1-2012/047931
US-A1- 2009 131 857
US-B1- 6 458 118
 WO-A1-2012/047931
US-A1- 2012 289 816
   
  • AMANO, YOSHIYUKI.: 'The cerebrospinal fluid production rate in the experimentally induced edematous brain and influences of dexamethasone upon it.' NAGOYA JOURNAL OF MEDICAL SCIENCE 1969, pages 427 - 441, XP055286518
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).